No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
279 |
4. Check minimum number of eventsNone |
279 |
5. Include endpointsNone |
279 |
6. Filter based on genotype QC (FinnGen only) |
258 |
Control definitions (FinnGen only)
- Control exclude
- AB1_INTESTINAL_INFECTIONS
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF13
Similar endpoints
↥List of similar endpoints to
Shigellosis
based on the number of shared cases.
Similar with more cases:
- Intestinal infectious diseases
- Certain infectious and parasitic diseases
- Any prescribed medicine buy
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 258 | 151 | 107 |
| Unadjusted period prevalence (%) | 0.05 | 0.05 | 0.05 |
| Median age at first event (years) | 43.56 | 38.82 | 50.25 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 279
- Matched controls
- 2790
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
A03
ICD-10 Finland
Shigellosis
+∞
118.4
105
*
A03.9
ICD-10 Finland
Shigellosis, unspecified
+∞
68.6
63
*
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
8.4
63.1
109
198
A03.3
ICD-10 Finland
Shigellosis due to Shigella sonnei
+∞
51.7
48
*
A03.0
ICD-10 Finland
Shigellosis due to Shigella dysenteriae
+∞
25.4
24
*
J01MA02
ATC
ciprofloxacin; systemic
3.4
22.1
133
592
A03.1
ICD-10 Finland
Shigellosis due to Shigella flexneri
+∞
20.0
19
*
D11
ICPC
Diarrhoea
3.8
17.0
62
197
Z2221
NOMESCO Finland
Medical doctor
3.0
17.0
105
462
R74
ICD-10 Finland
Abnormal serum enzyme levels
63.9
16.0
18
*
A03
ICPC
Fever
3.1
15.9
87
355
EB1AA, ,
SPAT
4.6
15.8
41
101
WX110, ,
SPAT
4.4
13.9
38
97
EB1SA, ,
SPAT
4.5
13.0
34
84
XF400
NOMESCO Finland
ECG with 12 standard connections
3.3
13.0
58
208
Z3226
NOMESCO Finland
Physiotherapist
3.0
12.7
69
277
00920
ICD-8 Finland
Diarrhoeal disease, Gastroenteritis (acuta) (infectiosa)
+∞
12.6
12
*
R50.9
ICD-10 Finland
Fever, unspecified
3.1
12.1
60
228
A56.3
ICD-10 Finland
Chlamydial infection of anus and rectum
36.7
11.4
14
*
R4110
NOMESCO Finland
Physiotherapy
2.5
10.7
91
455
A48
ICPC
General and Unspecified, Clarification/discussion RFE/demand
3.8
10.5
34
98
A54.6
ICD-10 Finland
Gonococcal infection of anus and rectum
+∞
10.5
10
*
L02
ICPC
Back symptom/complaint
3.2
10.3
45
158
SPAT1212
SPAT
Extensive examination of musculoskeletal system
3.8
10.1
33
96
R21
ICD-10 Finland
Rash and other nonspecific skin eruption
4.6
10.1
25
59
ZXD10
NOMESCO Finland
Scheduled procedure
2.3
9.8
114
649
A54.5
ICD-10 Finland
Gonococcal pharyngitis
57.0
9.7
11
*
SPAT1336
SPAT
Request for examination
4.9
9.7
22
48
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
2.9
9.5
49
189
A03.8
ICD-10 Finland
Other shigellosis
+∞
9.4
9
*
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
3.2
9.2
39
134
Z2446
NOMESCO Finland
Social worker
3.4
9.0
35
114
S29
ICPC
Skin symptom/complaint other
2.5
9.0
68
319
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.2
9.0
120
718
ZXE00
NOMESCO Finland
One hour or less
2.2
8.9
119
713
ZXE10
NOMESCO Finland
More than one and less than three hours
2.2
8.8
101
568
D09
ICPC
Nausea
3.8
8.8
28
80
R4120
NOMESCO Finland
Occupational therapy
3.8
8.8
28
80
A28
ICPC
Limited function/disability NOS
3.1
8.8
40
144
D06
ICPC
Abdominal pain localized other
3.2
8.7
36
122
A98
ICD-10 Finland
Other viral haemorrhagic fevers, not elsewhere classified
9.4
8.7
17
19
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.4
8.5
32
102
L28
ICPC
Limited function/disability (L)
2.8
8.5
47
188
A60
ICPC
General and Unspecified, Result test/procedure
4.2
8.5
23
58
D11
ICD-10 Finland
Benign neoplasm of major salivary glands
+∞
8.4
8
*
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.1
8.4
115
692
Z71.8
ICD-10 Finland
Other specified counselling
2.1
8.2
106
622
Z3231
NOMESCO Finland
Registered nurse
2.2
8.1
89
489
A51.0
ICD-10 Finland
Primary genital syphilis
46.3
7.8
9
*
Z11.3
ICD-10 Finland
Special screening examination for infections with a predominantly sexual mode of transmission
3.2
7.7
32
109
0049X
ICD-9 Finland
Shigellosis, unspecified
+∞
7.3
7
*
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
+∞
7.3
7
*
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
2.0
7.3
168
1201
R11
ICD-10 Finland
Nausea and vomiting
3.1
7.2
31
108
R55
ICD-10 Finland
Syncope and collapse
3.0
7.1
32
114
D10
ICPC
Vomiting
3.0
6.8
31
111
WX402
NOMESCO Finland
General anaesthesia
2.2
6.8
65
336
N30.0
ICD-10 Finland
Acute cystitis
2.4
6.7
50
231
A04
ICPC
Weakness/tiredness general
2.4
6.7
51
239
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
3.8
6.6
20
55
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.2
6.6
60
303
R2110
NOMESCO Finland
Giving the first information
3.6
6.6
22
65
K59.09
ICD-10 Finland
Constipation, unspecified
3.4
6.5
24
76
R02
ICD-10 Finland
Gangrene, not elsewhere classified
71.4
6.5
7
*
A54.0
ICD-10 Finland
Gonococcal infection of lower genitourinary tract without periurethral or accessory gland abscess
71.4
6.5
7
*
P01AB01
ATC
metronidazole; oral, rectal
1.9
6.4
108
685
SPAT1016
SPAT
Examination of vision
3.1
6.4
27
93
WX290, ,
SPAT
3.8
6.3
19
52
XF600
NOMESCO Finland
Bloodpressure measurement
3.6
6.3
21
62
A04.5
ICD-10 Finland
Campylobacter enteritis
27.3
6.3
8
*
N02AX02
ATC
tramadol; systemic, rectal
1.9
6.2
110
709
SPAT1283
SPAT
Restricted health certificate
2.1
6.1
71
394
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
3.2
6.1
24
79
M79.6
ICD-10 Finland
Pain in limb
1.9
6.1
117
773
R07.0
ICD-10 Finland
Pain in throat
3.0
6.0
27
96
U07
ICPC
Urine symptom/complaint other
3.1
6.0
25
85
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
62
176
4.24
20.09
2.4
2.0
26.72
30.24
u/l
0.89
54
147
42
91
5.26
18.92
2.0
1.4
—
—
—
0
0
33
63
5.81
17.00
1.8
1.1
—
—
—
0
0
33
64
5.71
16.72
1.8
1.1
—
—
—
0
0
83
331
3.15
15.79
4.0
2.4
0.75
1.03
e6/l
0.35
22
177
80
317
3.14
15.34
4.0
2.6
3.60
2.94
e6/l
0.17
20
165
29
62
5.10
13.15
1.8
1.4
—
—
—
0
0
62
246
2.95
11.59
6.1
1.9
—
—
—
0
0
54
198
3.14
11.58
6.2
1.9
—
—
—
0
0
169
1088
2.40
11.36
6.9
5.3
55.03
55.98
%
0.52
163
1027
170
1102
2.39
11.18
7.0
5.4
29.00
29.75
%
0.40
164
1040
105
557
2.42
10.88
5.0
2.7
0.15
0.37
e6/l
1.64
65
402
187
1274
2.42
10.83
12.0
8.6
4.00
4.01
e9/l
0.02
156
1104
22
49
4.79
9.48
1.6
2.2
—
—
—
0
0
15
11
14.33
9.29
4.5
1.4
—
—
—
0
0
137
865
2.15
8.92
6.7
5.3
1.21
1.22
mmol/l
0.82
129
792
41
149
3.05
8.84
2.0
1.3
—
—
—
0
0
93
524
2.16
7.93
1.6
1.6
1.29
1.38
mmol/l
0.38
88
435
116
720
2.05
7.60
2.0
1.8
99.83
94.87
pmol/l
0.56
58
358
65
338
2.20
6.65
3.1
3.0
512.62
260.37
ng/l
0.21
45
232
111
704
1.96
6.65
5.0
2.8
—
—
—
0
0
17
45
3.96
5.91
1.8
1.8
—
—
—
0
0
241
2037
2.34
5.79
16.9
10.1
89.16
88.96
ml/min/173m2
0.04
188
1627
259
2265
3.00
5.74
18.1
10.6
28.84
22.66
mg/l
1.91
218
1716
16
33
5.08
5.52
1.4
1.4
—
—
—
0
0
16
33
5.08
5.52
1.4
1.4
—
—
—
0
0
199
1589
1.88
5.33
8.7
6.4
82.98
79.91
u/l
0.36
189
1487
77
462
1.92
5.25
4.9
2.3
—
—
—
0
0
132
940
1.77
5.14
7.7
5.6
1.21
1.22
mmol/l
0.78
118
806
144
1063
1.73
4.85
4.2
3.2
0.00
0.00
estimate
-0.00
13
203
11
17
6.69
4.82
3.0
3.7
—
—
—
0
0
142
1049
1.72
4.73
4.2
3.1
0.00
0.00
estimate
-0.00
15
220
62
362
1.92
4.53
1.3
1.3
23.94
21.49
iu/ml
0.09
18
116
20
71
2.96
4.49
1.6
1.2
—
—
—
0
0
140
1048
1.67
4.31
6.6
4.3
0.00
0.00
estimate
-0.00
13
211
208
1735
1.78
4.24
4.3
3.4
—
—
—
0
0
38
191
2.15
4.17
1.7
1.7
—
—
—
0
0
38
191
2.15
4.17
1.7
1.6
—
—
—
0
0
194
1592
1.72
4.13
4.0
3.4
12.71
9.51
mm/h
1.86
181
1459
251
2237
2.22
4.01
19.3
11.8
138.97
139.70
mmol/l
4.23
243
2171
12
27
4.60
3.98
2.4
2.7
—
—
—
0
0
136
1025
1.64
3.98
7.4
5.6
14.03
12.11
umol/l
0.35
125
969
13
32
4.21
3.95
1.4
1.4
23384.50
13542.10
e6/l
—
6
20
67
418
1.79
3.94
2.7
2.9
1339.26
990.73
ng/l
0.41
56
348
11
23
4.93
3.91
1.3
1.2
—
—
—
0
0
11
23
4.93
3.91
1.3
1.2
—
—
—
0
0
11
24
4.73
3.78
1.3
1.2
—
—
—
0
0
11
24
4.73
3.78
1.3
1.2
—
—
—
0
0
11
24
4.73
3.78
1.3
1.2
—
—
—
0
0
11
24
4.73
3.78
1.3
1.0
—
—
—
0
0
23
97
2.49
3.76
1.9
1.7
—
—
—
0
0
12
29
4.28
3.75
1.7
1.2
—
—
—
0
0
13
34
3.96
3.74
1.5
1.4
—
—
—
0
0
12
30
4.13
3.64
1.4
1.3
—
—
—
0
0
132
1005
1.59
3.60
3.6
2.6
98.80
90.60
ug/l
0.27
125
934
250
2245
2.09
3.59
19.5
11.8
3.90
3.95
mmol/l
2.44
241
2174
22
93
2.48
3.58
1.2
1.7
—
—
—
0
0
67
433
1.72
3.46
4.8
2.2
—
—
—
0
0
47
273
1.87
3.46
1.8
1.8
—
—
—
0
0
260
2377
2.38
3.45
11.7
8.6
25.30
26.14
u/l
0.43
254
2301
71
469
1.69
3.38
2.2
1.9
2.24
2.94
mg/l
2.19
63
393
56
347
1.77
3.34
1.2
1.3
2.46
9.37
u/ml
1.67
17
132
10
23
4.47
3.34
1.4
1.1
—
—
—
0
0
106
778
1.58
3.31
5.0
4.1
36.23
36.52
g/l
0.17
100
735
84
584
1.63
3.28
1.7
1.6
—
—
—
0
0
71
481
1.64
3.05
1.9
2.1
—
—
—
0
0
12
37
3.34
2.97
1.3
1.4
5.67
6.29
u/ml
—
6
17
12
38
3.25
2.89
1.3
1.4
1.83
8.64
u/ml
—
6
14
79
561
1.57
2.77
1.4
1.3
5.75
1.64
u/ml
0.37
13
124
5
7
7.25
2.56
1.0
1.9
14.00
11.71
u/l
—
5
7
11
37
3.05
2.52
1.0
1.9
—
—
—
0
0
5
8
6.34
2.38
1.0
2.6
—
—
—
0
0
5
8
6.34
2.38
1.0
2.6
—
—
—
0
0
25
135
1.94
2.31
4.0
7.5
24.85
24.90
mmol/l
0.03
25
135
271
2594
2.56
2.28
27.3
16.0
39.73
40.63
%
2.40
265
2462
271
2591
2.60
2.27
26.8
16.0
258.28
253.75
e9/l
0.51
262
2521
64
453
1.54
2.25
2.2
1.8
1.03
1.14
mg/l
0.14
48
341
21
108
2.02
2.22
1.2
1.3
175.38
236.33
miu/ml
—
8
55
195
1714
1.46
2.18
3.7
3.7
14.27
14.62
pmol/l
1.27
179
1541
7
19
3.75
2.16
2.1
2.2
836.43
585.16
e6/l
—
7
19
271
2596
2.53
2.14
26.8
16.0
4.43
4.56
e12/l
5.20
258
2521
12
49
2.51
2.13
1.8
1.3
—
—
—
0
0
5
10
5.07
2.08
1.2
1.1
—
—
—
0
0
20
104
1.99
2.06
10.3
8.9
91.31
94.45
%
0.50
20
104
34
211
1.70
2.03
11.5
6.5
104.18
104.45
mmol/l
0.16
34
211
7
21
3.39
1.98
1.1
1.0
—
—
—
0
0
7
21
3.39
1.98
1.0
1.1
—
—
—
0
0
5
11
4.61
1.95
1.2
1.2
—
—
—
0
0
6
16
3.81
1.94
1.3
4.6
94.50
87.44
%
—
6
16
12
52
2.37
1.90
1.4
1.2
—
40.75
—
0
6
120
986
1.38
1.88
2.3
2.4
—
—
—
0
0
47
324
1.54
1.86
2.8
2.5
2.46
2.43
mmol/l
0.62
42
278
57
410
1.49
1.85
1.7
1.5
22.99
20.88
nmol/l
0.50
52
348
14
66
2.18
1.85
1.7
1.4
—
—
—
0
0
47
325
1.54
1.83
1.5
1.9
1.45
1.41
%
0.19
41
298
38
554
0.64
1.83
6.6
3.3
0.00
0.00
estimate
0.50
14
208
225
2062
1.47
1.77
4.5
4.3
1.81
1.87
mu/l
0.28
210
1896
28
173
1.69
1.72
3.9
2.8
—
—
—
0
0
64
480
1.43
1.68
2.7
2.5
335.03
4531.04
umol/l
1.78
59
425
19
107
1.83
1.59
10.7
8.6
0.66
0.72
%
0.25
19
107
64
821
0.71
1.57
4.7
3.2
—
—
—
0
0
19
108
1.81
1.55
10.7
8.3
1.17
1.48
%
0.72
19
108
28
180
1.62
1.50
8.3
7.3
11.53
12.78
kpa
0.83
28
172
28
180
1.62
1.50
8.3
7.3
4.96
5.15
kpa
0.28
28
172
20
117
1.76
1.49
1.5
1.5
22.36
22.31
iu/l
0.00
11
97
138
1189
1.32
1.49
5.9
4.1
6.84
6.43
mmol/l
1.10
127
1078
5
16
3.16
1.44
1.2
1.1
303.48
195.08
iu/ml
—
5
16
6
22
2.76
1.44
1.3
1.5
—
—
—
0
0
6
22
2.76
1.44
1.3
1.5
—
—
—
0
0
6
22
2.76
1.44
1.3
1.0
—
—
—
0
0
6
22
2.76
1.44
1.3
1.5
—
—
—
0
0
22
134
1.70
1.44
1.2
1.1
—
—
—
0
0
6
23
2.64
1.37
1.3
1.5
—
—
—
0
0
6
23
2.64
1.37
1.3
1.5
—
—
—
0
0
18
106
1.75
1.33
1.5
1.5
—
—
—
0
0
48
357
1.42
1.32
2.2
2.8
0.89
0.66
ug/l
0.62
27
214
10
48
2.12
1.29
1.4
1.2
—
—
—
0
0
10
49
2.08
1.23
1.2
1.5
288.40
307.40
ug/g
—
5
26
204
1881
1.31
1.22
4.9
4.8
38.61
38.72
mmol/mol
0.05
192
1758
13
71
1.87
1.21
1.5
1.2
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
10
50
2.04
1.18
2.7
2.6
0.32
0.34
u/ml
—
5
26
7
30
2.37
1.13
1.0
1.3
—
—
—
0
0
7
31
2.29
1.11
6.6
3.7
20.00
40.42
u/ml
—
7
31
8
41
1.98
1.09
1.4
1.3
—
—
—
0
0
8
41
1.98
1.09
1.0
1.1
—
—
—
0
0
7
32
2.22
1.09
1.6
1.4
—
—
—
0
0
63
508
1.31
1.06
3.1
3.8
4.63
10.36
mg/mmol
1.33
34
324
16
98
1.67
1.05
1.6
1.4
—
—
—
0
0
16
98
1.67
1.05
1.6
1.4
—
—
—
0
0
5
22
2.30
1.04
7.2
16.4
755.00
896.82
nmol/l
—
5
22
5
22
2.30
1.04
8.8
20.0
1678.80
1622.23
nmol/l
—
5
22
15
236
0.61
1.03
1.5
1.7
—
—
—
0
0
16
99
1.65
1.02
1.6
1.4
—
—
—
0
0
16
99
1.65
1.02
1.6
1.4
—
—
—
0
0
38
286
1.38
1.00
1.5
1.6
1198.37
1170.87
nmol/l
0.04
31
216
16
100
1.64
0.99
2.4
1.3
—
—
—
0
0
5
23
2.19
0.98
1.4
1.5
—
—
—
0
0
11
63
1.78
0.91
1.5
1.2
—
10.02
—
0
11
22
152
1.49
0.91
9.1
7.6
119.91
122.02
g/l
0.19
22
146
16
240
0.65
0.91
4.8
4.0
30.30
31.31
%
—
10
166
75
636
1.25
0.85
3.0
2.9
2.36
2.37
mmol/l
0.11
68
562
8
47
1.72
0.81
1.3
1.1
—
—
—
0
0
8
48
1.69
0.79
1.1
1.2
—
—
—
0
0
19
132
1.47
0.78
3.0
2.2
10.09
7.77
ug/l
0.18
14
115
11
68
1.64
0.73
2.0
1.9
—
—
—
0
0
18
126
1.46
0.72
11.4
2.4
57.75
70.92
ml/min/173m2
—
8
53
28
360
0.75
0.70
1.9
1.6
369.22
446.35
pmol/l
1.13
23
307
18
129
1.42
0.65
6.9
3.3
121.37
70.51
ng/l
0.68
18
115
8
49
1.65
0.62
3.8
2.4
—
—
—
0
0
163
1533
1.15
0.53
3.0
2.8
42.78
40.52
u/l
0.15
150
1443
6
39
1.55
0.53
1.0
1.1
—
—
—
0
0
47
402
1.20
0.50
1.4
1.5
—
—
—
0
0
218
2103
1.17
0.47
4.0
3.8
1.42
1.46
mmol/l
0.79
207
1969
5
83
0.60
0.46
2.2
1.7
—
—
—
0
0
55
482
1.18
0.46
3.5
3.9
25.63
21.26
%
0.72
27
207
219
2115
1.16
0.45
3.9
3.9
4.57
4.66
mmol/l
0.70
210
1993
215
2075
1.16
0.44
3.7
3.8
5.84
5.77
mmol/l
0.31
205
1919
5
32
1.57
0.42
2.2
1.4
—
—
—
0
0
10
70
1.44
0.42
1.4
1.9
173.00
234.75
pmol/l
—
10
65
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
0
17
0.00
0.41
0.0
1.8
—
0.17
—
0
6
62
685
0.88
0.37
4.2
2.9
19.66
39.42
ng/l
1.72
35
424
220
2137
1.14
0.36
4.4
4.3
2.78
2.79
mmol/l
0.03
211
1994
13
99
1.33
0.36
1.7
2.0
—
—
—
0
0
10
73
1.38
0.35
1.2
2.7
—
—
—
0
0
10
74
1.36
0.32
2.0
2.0
—
—
—
0
0
18
219
0.81
0.32
15.2
6.9
—
—
—
0
0
7
100
0.69
0.31
5.7
2.8
0.21
0.15
e6/l
—
7
94
64
589
1.11
0.28
4.5
4.3
3.45
1.84
ug/l
1.20
57
532
88
830
1.09
0.24
19.5
11.1
1.38
1.19
inr
0.81
27
254
5
40
1.25
0.22
1.4
1.2
—
108.00
—
0
9
0
11
0.00
0.21
0.0
2.6
—
58.09
—
0
11
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
12
0.00
0.21
0.0
1.9
—
6.42
—
0
12
0
14
0.00
0.20
0.0
1.1
—
0.98
—
0
9
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
9
78
1.16
0.15
1.2
1.6
—
—
—
0
0
18
161
1.13
0.13
4.2
4.3
20.12
77.84
ug/l
0.57
13
130
16
143
1.13
0.12
3.9
2.2
2170.90
2031.50
u/l
—
6
50
21
192
1.10
0.11
1.7
1.5
—
—
—
0
0
9
100
0.90
0.06
6.1
6.2
24.00
24.72
mmol/l
—
9
94
201
2026
0.97
0.05
3.5
3.5
1.33
1.26
mmol/l
0.50
187
1893
14
130
1.08
0.04
1.3
1.4
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.9
—
—
—
0
0
0
6
0.00
-0.00
0.0
3.2
—
59.20
—
0
6
0
8
0.00
-0.00
0.0
1.9
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.8
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
7.39
—
0
7
0
9
0.00
-0.00
0.0
1.9
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.4
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.9
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.4
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.9
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.9
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: AB1_SHIGELLOSIS_WIDE – Shigellosis
GWS hits: -
This endpoint is excluded (different definition than used in FinnGen).